Effects of Christensenella minuta lipopolysaccharide on RAW 264.7 macrophages activation

Microbial Pathogenesis

Volumn 125, Issue , 2018, Pages 411-417

  Yang, Yingyin ^a   Gu, Huawei ^a   Sun, Qiuli ^a   Wang, Jufang ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Christensenella minuta; Genome; Lipopolysaccharide; RAW 264.7 macrophages; Toxicity

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; CARBOHYDRATE SYNTHESIS; CELL PROLIFERATION; CHRISTENSENELLA MINUTA; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; POLYSACCHARIDE STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION; WHOLE GENOME SEQUENCING; ANIMAL; BIOSYNTHESIS; CLOSTRIDIALES; DNA SEQUENCE; DRUG EFFECT; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACROPHAGE; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANIMALS; BIOSYNTHETIC PATHWAYS; CELL PROLIFERATION; CLOSTRIDIALES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENOME, BACTERIAL; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; PHAGOCYTOSIS; RAW 264.7 CELLS; REACTIVE OXYGEN SPECIES; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION;

EID: 85054452942     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2018.10.005     Document Type: Article

References (39)

1. Morotomi, M., Nagai, F., Watanabe, Y., Description of Christensenella minuta gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenellaceae fam. nov. Int. J. Syst. Evol. Microbiol. 62 (2012), 144–149.
2. Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., et al. Human genetics shape the gut microbiome. Cell 159 (2014), 789–799.
3. Borrelli, L., Coretti, L., Dipineto, L., Bovera, F., Menna, F., Chiariotti, L., et al. Insect-based diet, a promising nutritional source, modulates gut microbiota composition and SCFAs production in laying hens. Sci. Rep., 7, 2017, 16269.
4. Li, R., Wang, H., Shi, Q., Wang, N., Zhang, Z., Xiong, C., et al. Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice. PloS One, 12, 2017, e0181690.
5. de Groot, P.F., Belzer, C., Aydin, O., Levin, E., Levels, J.H., Aalvink, S., et al. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PloS One, 12, 2017, e0188475.
6. Alonso, B.L., Irigoyen von Sierakowski, A., Saez Nieto, J.A., Rosel, A.B., First report of human infection by Christensenella minuta, a gram-negative, strickly anaerobic rod that inhabits the human intestine. Anaerobe 44 (2017), 124–125.
7. Ndongo, S., Khelaifia, S., Fournier, P.E., Raoult, D., Christensenella massiliensis, a new bacterial species isolated from the human gut. New Microbes and New Infections, 12, 2016, 69–70.
8. Ndongo, S., Dubourg, G., Khelaifia, S., Fournier, P.E., Raoult, D., Christensenella timonensis, a new bacterial species isolated from the human gut. New Microbes and New Infections, 13, 2016, 32–33.
9. Maldonado, R.F., Sa-Correia, I., Valvano, M.A., Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev. 40 (2016), 480–493.
10. Lu, Y.C., Yeh, W.C., Ohashi, P.S., LPS/TLR4 signal transduction pathway. Cytokine 42 (2008), 145–151.
11. Medzhitov, R., Origin and physiological roles of inflammation. Nature 454 (2008), 428–435.
12. Choi, E.Y., Jin, J.Y., Lee, J.Y., Choi, J.I., Choi, I.S., Kim, S.J., Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-kappaB and STAT1 activity. J. Pineal Res. 50 (2011), 197–206.
13. Schmittgen, T.D., Livak, K.J., Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3 (2008), 1101–1108.
14. Polissi, A., Sperandeo, P., The lipopolysaccharide export pathway in Escherichia coli: structure, organization and regulated assembly of the Lpt machinery. Mar. Drugs 12 (2014), 1023–1042.
15. King, J.D., Kocincova, D., Westman, E.L., Lam, J.S., Review: lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun. 15 (2009), 261–312.
16. Schnaitman, C.A., Klena, J.D., Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol. Rev. 57 (1993), 655–682.
17. Islam, S.T., Lam, J.S., Synthesis of bacterial polysaccharides via the Wzx/Wzy-dependent pathway. Can. J. Microbiol. 60 (2014), 697–716.
18. Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S.A., Mardani, F., et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233 (2018), 6425–6440.
19. Wu, T.-T., Chen, T.-L., Chen, R.-M., Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol. Lett. 191 (2009), 195–202.
20. Pires, B.R.B., Silva, R., Ferreira, G.M., Abdelhay, E., NF-kappaB: two sides of the same coin. Genes, 9, 2018.
21. Fan, C., Wu, L.H., Zhang, G.F., Xu, F., Zhang, S., Zhang, X., et al. 4'-Hydroxywogonin suppresses lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages and acute lung injury mice. PloS One, 12, 2017, e0181191.
22. Xu, H., Ling, J., Gao, Q., He, H., Mu, X., Yan, Z., et al. Role of the lpxM lipid A biosynthesis pathway gene in pathogenicity of avian pathogenic Escherichia coli strain E058 in a chicken infection model. Vet. Microbiol. 166 (2013), 516–526.
23. van der Ley, P., Steeghs, L., Hamstra, H.J., ten Hove, J., Zomer, B., van Alphen, L., Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immun. 69 (2001), 5981–5990.
24. Maldonado, R.F., Sácorreia, I., Valvano, M.A., Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev., 40, 2016, 480.
25. Kim, T.H., Pinkham, J.T., Heninger, S.J., Chalabaev, S., Kasper, D.L., Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine. JID (J. Infect. Dis.), 205, 2012, 1056.
26. Kong, Q., Yang, J., Liu, Q., Alamuri, P., Roland, K.L., Roy Curtiss, I., Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium. Infect. Immun. 79 (2011), 4227–4239.
27. Grozdanov, L., Zahringer, U., Blum-Oehler, G., Brade, L., Henne, A., Knirel, Y.A., et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J. Bacteriol. 184 (2002), 5912–5925.
28. Miller, S.I., Ernst, R.K., Bader, M.W., LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3 (2005), 36–46.
29. Zhou, X.Y., Wu, P., Zhang, L., Xiong, W., Li, Y.S., Feng, Y.M., et al. Effects of lipoxin A(4) on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264.7 macrophages through modulation of G-CSF secretion. Inflamm. Res. 56 (2007), 324–333.
30. Wu, J., Li, M., Liu, L., An, Q., Zhang, J., Zhang, J., et al. Nitric oxide and interleukins are involved in cell proliferation of RAW 264.7 macrophages activated by viili exopolysaccharides. Inflammation 36 (2013), 954–961.
31. Wallace, J.L., Chin, B.C., Inflammatory mediators in gastrointestinal defense and injury. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York, NY), 214, 1997, 192–203.
32. Seo, Y.J., Jeong, M., Lee, K.T., Jang, D.S., Choi, J.H., Isocyperol, isolated from the rhizomes of Cyperus rotundus, inhibits LPS-induced inflammatory responses via suppression of the NF-kappaB and STAT3 pathways and ROS stress in LPS-stimulated RAW 264.7 cells. Int. Immunopharm. 38 (2016), 61–69.
33. Zhang, X., Wang, Y., Xiao, C., Wei, Z., Wang, J., Yang, Z., et al. Resveratrol inhibits LPS-induced mice mastitis through attenuating the MAPK and NF-kappaB signaling pathway. Microb. Pathog. 107 (2017), 462–467.
34. Christoffersen, T.E., Hult, L.T., Kuczkowska, K., Moe, K.M., Skeie, S., Lea, T., et al. In vitro comparison of the effects of probiotic, commensal and pathogenic strains on macrophage polarization. Probiotics Antimicrob Proteins, 6, 2014, 1–10.
35. Becker, H.M., Apladas, A., Scharl, M., Fried, M., Rogler, G., Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells. Digestion 89 (2014), 110–118.
36. Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Environ. Microbiol. 81 (2015), 3655–3662.
37. de Heredia, F.P., Gomez-Martinez, S., Marcos, A., Obesity, inflammation and the immune system. Proc. Nutr. Soc. 71 (2012), 332–338.
38. Lim, S.-M., Kim, D.-H., Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-κB activation and lipopolysaccharide production by gut microbiota. Nutr. Res. 41 (2017), 86–96.
39. Zariri, A., van der Ley, P., Biosynthetically engineered lipopolysaccharide as vaccine adjuvant. Expet Rev. Vaccine 14 (2015), 861–876.